Cancer BiologybioRxiv
Wnt/β-catenin inhibition disrupts drug-tolerance in isogenic carboplatin-resistant models of Triple-Negative Breast Cancer.
W. A. Abreu de Oliveira, S. Moens, Y. El Laithy…·F. Lluis
This study shows that inhibiting Wnt/β-catenin signaling resensitizes carboplatin-resistant TNBC models to chemotherapy, suggesting a synergistic therapeutic strategy.
DOI 10.3389/fonc.2021.705384